Background
Despite recent progress in the management of respiratory complications due to drowning [
1,
2], criteria to initiate antibiotic or to collect respiratory samples are lacking [
2‐
4]. In addition, available data on the microorganisms involved in drowning-associated pneumonia are too scarce to recommend a straightforward antibiotic strategy [
3]. Two recent series on freshwater drowning in urban areas, from Paris and Amsterdam region with, respectively, 37 and 49 patients [
5,
6], described a significant proportion of MDR bacteria or presence of fungi in early respiratory samples suggesting the use of broad-spectrum antibiotics or even empirical antifungal therapy. Water composition (i.e., freshwater or seawater) and locality may influence such susceptibility patterns [
2]. However, to the best of our knowledge, microbial data in seawater drowning-associated pneumonia are very scarce and generally gathered from cases reports [
7‐
10] or reviews of cases from warm seas [
3] but none from temperate Mediterranean zones.
The aim of this study is to describe the bacterial species and their antibiotic susceptibility patterns recovered from early respiratory samples of drowning-associated pneumonia from seawater drowning patients in the Mediterranean Sea.
Results
Demographics
From January 2003 to April 2013, 74 patients were admitted for seawater drowning to the two ICU. None of them was excluded.
The male-to-female sex ratio was 1.85, and the median age was 68 (51–77) years. Thirty patients (41%) presented out-of-hospital cardiac arrest. Nineteen patients died during their ICU stay, defining a 26% ICU mortality rate. The median SAPS2 score was 45 (30–65). The main objectified causes for drowning were medical with 22/74 (30%) cases of divers medicals pathologies (such as seizures or cardiovascular dysfunction). Other causes were 16 (22%) sports-related injuries or unspecified trauma (including those occurring under the influence of alcohol), 7 (9%) physical exhaustion and 6 (8%) suicides. Unknown causes accounted for 23 (31%) cases in which resuscitation was carried out without prior knowledge of the time of drowning. Patient characteristics are summarized in Table
2.
Table 2
Demographics and clinical characteristics of the patients
At admission |
Age, years | 68 (51–77) |
Male sex—no. (%) | 48 (65) |
Initial cardiac arrest—no. (%) | 30 (41) |
Drowning grade | 5 (3–6) |
In the ICU |
Early pneumonia—no. (%) | 36 (49) |
Patients receiving antibiotics during the first 48 h—no (%) | 44 (59) |
Respiratory samples collected within the first 48 h—no. (%) | 24 (32) |
Positive respiratory samples collected within the first 48 h—no. (%) | 16 (22) |
Pneumonia treated empirically with AMC—no. (% of 36) | 34 (94) |
Appropriate empirical treatment within the first 48 h—no. (% of 16) | 8 (50) |
ARDS—no. (%) | 25 (34) |
SAPS2 score | 45 (30–65) |
Invasive mechanically ventilated patients—no. (%) | 51 (69) |
Duration of mechanical ventilation, days | 1 (0–4) |
Length of stay, days | 3 (2–7) |
Mortality rate in the ICU—no. (%) | 19 (26) |
All patients were found at sea in a similar coastal environment within 300 meters of the coast. In 61 (84%) cases, drowning occurred during the summer and spring.
Pneumonia, respiratory samples and bacteriological data
Of the 74 patients, four died within the first 24 h of admission and before any bacteriological sample could be obtained. Thirty-six patients (49%) were diagnosed and curatively treated for pneumonia. Twenty-five (34%) had ARDS. Four patients (5%) received curative antibiotics (more than 24 h) without proven pneumonia diagnosis and without respiratory sample during the first 48 h. Four additional patients (5%) received antibiotics for less than 24 h after admission, until the medical team challenged the diagnosis of pneumonia. Finally, 44 patients (59%) received antibiotics; among them, 40 (54%) received antibiotics for more than 24 h during the first week of hospitalization.
Respiratory specimens were obtained from 24 (32%) patients within the first 48 h of admission to the ICU with 19 (79%) protected distal samples and 5 (21%) tracheal aspirates. Bacteria were isolated at a significant count from 16 respiratory samples (22% of all patients and 67% of the early respiratory samples), and 24 different bacterial species were identified.
Enterobacter spp. were the most frequent microorganisms followed by
Streptococcus pneumonia and
Staphylococcus aureus. Pseudomonas aeruginosa was found in only one case. No fungi were isolated (Table
3).
Table 3
Identification of microorganisms isolated from respiratory samples
Aerobic Gram-negative bacilli | 14 (58%) |
Enterobacter cloacae
| 3a
|
Enterobacter aerogenes
| 2a
|
Escherichia coli
| 2 |
Citrobacter koserii
| 2 |
Klebsiella pneumoniae
| 1 |
Klebsiella oxytoca
| 1 |
Haemophilus influenzae
| 2 |
Pseudomonas aeruginosa
| 1a
|
Gram-positive aerobic cocci | 10 (42%) |
Streptococcus pneumoniae
| 4 |
Staphylococcus aureus
| 3 |
Indefinite oral flora | 3 |
Antibiotic susceptibility testing showed chromosomal penicillinase in four cases (for two
Klebsiella spp. and two
Citrobacter koserii) with a preserved susceptibility to amoxicillin–clavulanate (AMC). An inducible chromosome-encoded AmpC cephalosporinase was present in six strains: five
Enterobacter spp. and one
Pseudomonas aeruginosa.
P. aeruginosa isolate is also resistant to ticarcillin, ticarcillin–clavulanate and aztreonam due to overexpression of MexAB-OprM efflux pump (Table
4) but did not qualify as a multidrug-resistant (MDR) bacteria according to international criteria [
21]. Five respiratory samples had at least one strain with bacterial resistance to AMC. Overall, resistance to AMC was observed in 5/16 (31%) of early respiratory samples and in 6/24 (25%) bacterial species (Table
3). All cases of AMC resistance were observed for the Gram-negative bacilli species with 6/14 (43%) resistant.
Table 4
Mechanisms of betalactamins resistance in strains
Natural resistance | 10 (77%) |
Chromosomal penicillinase: Klebsiella spp./Citrobacter koserii
| 4 |
AmpC cephalosporinase: Enterobacter spp./Pseudomonas aeruginosa
| 6 |
Acquired resistance | 3 (23%) |
MexAB-OprM efflux pump: Pseudomonas aeruginosa
| 1 |
Inducible penicillinase: Staphylococcus aureus
| 2 |
Characteristics and outcomes of patients according to the resistance of the microorganisms
Compared to patients with sensitive microorganisms, patients with naturally resistant microorganism to AMC, found during the first 48 h, had a higher rate of cardiac arrest (
p = 0.026), higher drowning grade (
p = 0.013), longer duration of initial resuscitation (
p = 0.004), longer duration of mechanical ventilation (
p = 0.025) and a higher mortality rate in ICU (
p = 0.013). The SAPS2 score was not significantly different between the two groups nor the age, sex, initial Glasgow score, number of comorbidities (such as COPD, diabetes, coronary disease and chronic kidney disease), rate of invasive ventilation and length of stay (Table
5).
Table 5
Clinical characteristics and outcomes of patients with positives respiratory samples according to the sensitivity to amoxicillin-clavulanate of the microorganisms found
Characteristics at admission |
Age, years | 53 (44–72) | 68 (60–71) | 0.571 |
Male sex—no. (%) | 6 (55) | 3 (60) | 1 |
Initial cardiac arrest—no. (%) | 3 (27) | 5 (100) | 0.026 |
Low flow, minutes | 0 (0–1) | 8 (5–10) | 0.004 |
Drowning grade | 5 (4–6) | 6 (6–6) | 0.013 |
Initial Glasgow score | 4 (3–11) | 3 (3–3) | 0.051 |
SAPS2 score | 45 (37–52) | 65 (65–66) | 0.069 |
Various comorbidities (COPD, diabetes, coronary disease, kidney malignancy)—no. (%) | 3 (27) | 2 (40) | 1 |
Outcome |
Invasive mechanically ventilated patients—no. (%) | 10 (91) | 5 (100) | 1 |
Duration of mechanical ventilation, days | 2 (1–5) | 14 (6–19) | 0.025 |
Length of stay, days | 4 (2–6) | 7 (6–19) | 0.3 |
Mortality rate in the ICU—no. (%) | 1 (9) | 4 (80) | 0.013 |
Type of antibiotic therapy and adaptation to the microbiological results
AMC was the most common empiric antimicrobial treatment within the first 48 h (in 34/36 cases, 94%). However, two patients received, on admission, piperacillin–tazobactam as empiric treatment that was downgraded to AMC after obtaining the results of antibiotic susceptibility testing. Thirty-three patients received AMC as definitive treatment, and another three received cephalosporin for infection due to Enterobacter spp. The median duration of the antibiotic treatment was 7 (5–7) days.
All patients with positive respiratory specimens were initially treated empirically, 8/16 (50%) had appropriate empirical treatment, 4/16 (25%) had their treatment modified after receiving the bacteriological results (adapted to culture and susceptibility testing), 3/16 (19%) did not benefit from adaptation of their treatment to the microbiological results without a clear explanation mentioned in the medical record, but survived in the ICU. One patient died in the ICU without adaptation of the antibiotic treatment because the decision to limit life-sustaining therapies was taken before obtaining the final bacteriological results.
Discussion
This 10-year retrospective study is to date the largest cohort of early respiratory sample collection from seawater drowning patients. We found that wild-type
Enterobacter spp. is the most represented bacterial species and is likely due to aspiration of contaminated water or endogen flora. Among the respiratory samples collected, 5/16 (31%) grew bacteria with natural resistance to amoxicillin–clavulanate, the first-line antibiotic commonly used in our cohort. Unlike freshwater drowning-associated pneumonia, no specific MDR bacteria nor fungi were found [
5,
6].
Pneumonia appears to be a common complication in large series of drowning survivors admitted to ICU [
4] and was diagnosed in nearly half of all patients in our series. Antimicrobial susceptibility patterns are currently debated as illustrated in recent series of freshwater drowning in urban areas. Low rates of antibiotic resistance were found in respiratory samples from our patients. Only one strain of
Pseudomonas aeruginosa was found, and despite showing resistance to ticarcillin, it did not qualify as a MDR species [
21].
However, resistance to AMC was seen in a third of cases mainly due to Enterobacter spp. This chromosomal resistance pattern could not be associated with a specific population in our study, but these findings should encourage clinicians to perform respiratory sample collection as early as possible to avoid inappropriate antibiotic therapy.
We cannot identify the pathophysiological or environmental processes that would explain the microbial findings. The bacterial species that were isolated are likely to come from the oro-pharyngeal and/or gastric flora and would suggest aspiration pneumonia as described in previous series [
22]. Conversely, the large proportion of
Enterobacter spp. that was identified in our series is not typical of aspiration pneumonia and suggests seawater inhalation.
Accidental bacterial flora constituted by fecal contamination has been frequently described in seawater [
23], and this contamination could explain the bacterial findings. French local authorities are therefore frequently compelled to specifically quantify this flora as a marker of marine pollution, but their analysis mainly focuses on microorganisms of interest to reflect human fecal pollution (
Escherichia coli and
Enterococcus spp.). Pollution by antibiotic substances in freshwater has been described near urban areas [
24] but poorly studied in seawater. Further bacteriological studies into the marine environment are needed to understand the involvement of fecal flora contaminating seawater in the pathophysiology of pneumonia associated with drowning.
To reduce the risk of emergence of AmpC-hyperproducing
Enterobacteriaceae, European guidelines discourage the use of third-generation cephalosporins as single-drug therapy against
Enterobacter spp. [
25]. When antibiotic treatment cannot be delayed, fourth-generation cephalosporin such as cefepime could be suggested as a first-line treatment and later downgraded according to bacteriological results. When direct examination can be rapidly obtained, cefepime may be kept specifically for Gram-negative bacilli, whereas Gram-positive cocci could be treated with amino-penicillin combined with a beta-lactamase inhibitor. The authors highlight that antibiotic treatments should always be tailored to local epidemiological microbial data.
Patients presenting with an AMC-resistant bacteria respiratory infection seemed to have a more severe initial clinical presentation (more cardiac arrest, longer resuscitation duration and higher drowning grade) and worse outcome (duration of mechanical ventilation, mortality in ICU), which was not associated with specific demographic characteristics (age, sex or comorbidity). Indeed half of them were less than 65 years and had never been hospitalized.
This point should be specifically addressed in a larger prospective study and a larger antibiotic spectrum discussed for patient with an initial severe clinical presentation notably after cardiac arrest and a high drowning grade.
Our results show a clear difference between seawater and freshwater drowning-associated pneumonia, with recent data promoting the use of a broad-spectrum antibiotic and even suggesting empirical antifungal therapy [
5,
6]. Should this be confirmed in a future prospective study combined with environmental analysis, the water composition should define the antimicrobial strategy for empirical treatment.
Limitations
This study represents a local population admitted to the two intensive care units with the biggest local recruitment of severe drowning. However, patients were all found in a similar coastal environment and mostly during the summer and spring. The marine bacterial ecology may change according to the season, location and human pollution, but the impact of such modifications is still unknown and can be minimal if the main mechanism involved is aspiration of the endogen flora of the patients. Indeed, seawater samples have not been described in our study because they were not considered to represent the water composition during the ten years of the study. Such samples could be analyzed in a future prospective study and be compared with respiratory sputum collected from patients during the same period.
Only 24/36 patients presenting with early pneumonia had a respiratory sample. This may affect the prevalence of the susceptible microorganisms observed in this study.
The absence of anaerobic bacteria found in the respiratory samples does not formally exclude their potential impact in the pathogenic process of pneumonia associated with seawater drowning. Indeed, these bacteria are fragile and require specific conditions and media for culture [
26,
27]. Even if we cannot formally exclude anaerobic germs in this inhalation context, according to our results treatment with specific empirical antibiotic against these bacteria seems unnecessary.
Finally, the diagnosis of pneumonia is difficult for this population. An X-ray and biomarkers cannot be considered as a relevant tool to confirm or rule out diagnosis. Bacteriological samples may be of clinical, economical and of ecological interest.
Conclusions
This cohort is the largest providing early respiratory samples from seawater drowning patients. Unlike recent data from freshwater drowning series, microorganisms found are mostly bacteria with a low rate of antibiotic resistance suggesting that drowning environment influenced previous observations. When empirical antibiotic therapy is required after seawater drowning, systematic broad-spectrum antibiotics appear unnecessary. Early respiratory sample collection should nonetheless be mandatory to avoid inappropriate therapy. Empirical cephalosporin could be proposed for the most severe patients or, if a direct examination can be rapidly performed, for Gram-negative bacilli, whereas patients with Gram-positive cocci could be treated with amino-penicillin combined with a beta-lactamase inhibitor.
Authors’ contributions
AR, PED, DD and JD had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. AR, HQ, CI, GB and CP contributed to the study conception; AR, DD, ND and JD contributed to the data acquisition, analysis and interpretation; AR, PED, DD, NM, ND, CP, RR and JD contributed to drafting the manuscript; and AR, PED, DD, HQ, NM, ND, CP, RR and JD contributed to revising the manuscript for important intellectual content and approving the final copy. All authors read and approved the final manuscript.